{
    "radiographic_examinations": [
        {
            "procedure_name": "Transabdominal and transvaginal ultrasonography",
            "date": "Not specified",
            "findings": "Normal-size uterus (5.9 cm in length), abnormally heterogeneous and thickened endometrial lining (measuring up to 1 cm), normal kidneys and ovaries.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Chest radiography",
            "date": "Not specified",
            "findings": "Normal.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT of the chest, abdomen, and pelvis",
            "date": "1 month after the completion of therapy",
            "findings": "No evidence of cancer in the chest or upper abdomen, but soft-tissue densities in the pelvis thought to be resolving postoperative inflammatory changes.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT of the abdomen and pelvis",
            "date": "11 months after the completion of chemotherapy",
            "findings": "Occlusion of the inferior vena cava by a circumferential retroperitoneal soft-tissue mass measuring approximately 4 cm and two lesions in the liver (approximately 5 mm in greatest dimension).",
            "changes_over_time": "Findings suggest tumor recurrence."
        },
        {
            "procedure_name": "Integrated whole-body 18F-fluorodeoxyglucose (FDG) PET and CT",
            "date": "11 days after the previous CT scan",
            "findings": "Marked FDG avidity in the retroperitoneal mass and liver lesions, increased size and number of liver lesions since the previous CT scan, and a focus of intense tracer uptake in the L2 vertebral body consistent with metastasis.",
            "changes_over_time": "Increasing size and number of liver lesions since the previous CT scan."
        }
    ]
}